The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

Bibliographic Details
Main Author:	Claudia C. Dobler
Format:	Article
Language:	English
Published:	European Respiratory Society 2018-12-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/14/4/333.full

Similar Items

Current appraisal of single inhaler triple therapy in COPD
by: Lipworth B, et al.
Published: (2018-09-01)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
by: David M.G. Halpin, et al.
Published: (2021-06-01)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
by: Bourbeau J, et al.
Published: (2021-03-01)

Single inhaler triple therapy in COPD – all that glitters is not gold
by: Kartik Deshmukh, et al.
Published: (2021-04-01)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
by: Ismaila AS, et al.
Published: (2019-11-01)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
by: Ian Naya, et al.
Published: (2018-10-01)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
by: David M.G. Halpin, et al.
Published: (2018-05-01)

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
by: Elisabeth Fenwick, et al.
Published: (2021-03-01)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
by: Jaco Voorham, et al.
Published: (2019-08-01)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
by: Kiff C, et al.
Published: (2018-09-01)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
by: Sandeep Bansal, et al.
Published: (2021-05-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
by: Mario Cazzola, et al.
Published: (2019-11-01)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
by: López-Campos JL, et al.
Published: (2020-07-01)

Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD
by: Miravitlles M, et al.
Published: (2020-07-01)

Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
by: Shih-Yu Chen, et al.
Published: (2021-06-01)

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
by: Nicola C. Day, et al.
Published: (2020-06-01)

Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis
by: Yixuan Jiang, et al.
Published: (2021-01-01)

Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis.
by: Yixuan Jiang, et al.
Published: (2021-01-01)

Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain
by: Alcázar-Navarrete B, et al.
Published: (2021-07-01)

Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
by: Gary T. Ferguson, et al.
Published: (2020-05-01)

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
by: Helgo Magnussen, et al.
Published: (2021-01-01)

Use of dry powder inhalers in acute exacerbations of asthma and COPD
by: Olof Selroos, et al.
Published: (2009-04-01)

Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study
by: Dalon F, et al.
Published: (2019-08-01)

The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
by: Lai CC, et al.
Published: (2019-07-01)

The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population
by: Kato M, et al.
Published: (2019-12-01)

Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
by: Jinping Zheng, et al.
Published: (2021-03-01)

When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals
by: Gaduzo S, et al.
Published: (2019-02-01)

The Effects Of Single Inhaler Triple Therapy Vs Single Inhaler Dual Therapy Or Separate Triple Therapy For The Management Of Chronic Obstructive Pulmonary Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials [Corrigendum]
by: Lai CC, et al.
Published: (2020-01-01)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
by: Benson VS, et al.
Published: (2019-11-01)

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study
by: Sicras-Mainar A, et al.
Published: (2020-12-01)

Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
by: Huanyu Long, et al.
Published: (2021-07-01)

Symptomatic burden of COPD for patients receiving dual or triple therapy
by: Chen S, et al.
Published: (2018-04-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui SH, et al.
Published: (2018-11-01)

Impact of exacerbations on COPD
by: A. Anzueto
Published: (2010-06-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

Improving adherence with inhaler therapy in COPD
by: Suzanne C Lareau, et al.
Published: (2010-11-01)

Single Inhaler LABA/LAMA for COPD
by: Mario Malerba, et al.
Published: (2019-04-01)

Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review
by: Zhang S, et al.
Published: (2020-02-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)